Enrichment analysis of genes dysregulated following Sb 216763 treatment
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00014084
TitleEnrichment analysis of genes dysregulated following Sb 216763 treatment
DescriptionAn enrichment analysis was performed on the top most dyresgulated genes determined by applying the principal angle method to compare gene expression between Sb 216763 treated cells and untreated control cells in the RS4.11 leukemia cell line cell type.
Analysis URLhttp://amp.pharm.mssm.edu/PAEA?id=3089219
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis Curatorcadimo
CREEDS IDdrug:3266
Cell TypeRS4.11 leukemia cell line
Drug NameSb 216763
Organismhuman
PubChem CID176158
SMILES IDCN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C(C=C(C=C4)Cl)Cl
Characteristic Direction parameters
Control SamplesGSM492838, GSM492846
Perturbed SamplesGSM492847, GSM492848, GSM492849
Tools used in the analysis
Dataset Accession
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
PAEA
Published November 2015
Enrichment analysis tool implementing the principal angle method
3879
Datasets used in the analysis
Keyword
Tool Name
GSE19736
Gene Expression Omnibus
Glycogen synthase kinase 3 inhibitor effect on MLL leukemia cells
12
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.